(Q28240591)

2

0 references

M Bundo

3

0 references

K Ikeda

4

0 references

T Kato

The pharmacologic treatment of depression

5

0 references

language of work or name

English

0 references

publication date

April 2004

0 references

published in

Molecular Psychiatry

0 references

volume

9

0 references

issue

4

0 references

page(s)

406-16

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001437

Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001437

Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001437

Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001437

Gene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001437

Gene expression differences in bipolar disorder revealed by cDNA array analysis of post-mortem frontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001437

Are schizophrenic and bipolar disorders related? A review of family and molecular studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001437

Mitochondrial calcium response in human transformed lymphoblastoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001437

The human Y chromosome, in the light of evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001437

Hsp27 upregulation and phosphorylation is required for injured sensory and motor neuron survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001437

PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001437

Glutamatergic mechanisms in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001437

Glutamate and its role in psychiatric illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001437

Association study of polymorphisms in the GluR5 kainate receptor gene (GRIK1) with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001437

Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001437

Variability of 5-HT2C receptor cys23ser polymorphism among European populations and vulnerability to affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001437

The NOTCH4 locus is associated with susceptibility to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001437

Association analysis of NOTCH4 loci in schizophrenia using family and population-based controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001437

Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001437

Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001437

Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001437

Maturation and maintenance of the neuromuscular synapse: genetic evidence for roles of the dystrophin--glycoprotein complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001437

Syntrophin-dependent expression and localization of Aquaporin-4 water channel protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001437

Delayed onset of brain edema and mislocalization of aquaporin-4 in dystrophin-null transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001437

Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001437

Pharmacogenetics and the serotonin system: initial studies and future directions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001437

Protein-protein interaction of zinc finger LIM domains with protein kinase C

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001437

Splicing regulation in neurons: tinkering with cell-specific control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001437

The action of molecular chaperones in the early secretory pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001437

Associated disturbances in calcium homeostasis and G protein-mediated cAMP signaling in bipolar I disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001437

Altered IMPA2 gene expression and calcium homeostasis in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001437

Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001437

Reduced neuropeptide Y mRNA levels in the frontal cortex of people with schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001437

7 January 2021

The stanley foundation brain collection and neuropathology consortium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001437

7 January 2021

Gene-expression profile of the ageing brain in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001437

7 January 2021

Polyglutamine protein aggregates are dynamic

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001437

7 January 2021

Schizophrenia, chronic hospitalization and the 5-HT2C receptor gene.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001437

7 January 2021

Failure to confirm NOTCH4 association with schizophrenia in a large population-based sample from Scotland

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001437

7 January 2021

Genetic analysis of the (CTG)n NOTCH4 polymorphism in 65 multiplex bipolar pedigrees

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001437

7 January 2021

A PKC epsilon-ENH-channel complex specifically modulates N-type Ca2+ channels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001437

7 January 2021

Identifiers

DOI

10.1038/SJ.MP.4001437

1 reference

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

1515618

1009774041

0 references

Fatcat ID

release_otmsyzmwwbgn5meoqhpztuuhiy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/otmsyzmwwbgn5meoqhpztuuhiy

24 November 2022

mapped directly with Wikidata item

1515618

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference